PL2830645T3 - Neuregulina do zastosowania w leczeniu uszkodzenia nerwu obwodowego - Google Patents

Neuregulina do zastosowania w leczeniu uszkodzenia nerwu obwodowego

Info

Publication number
PL2830645T3
PL2830645T3 PL13716919T PL13716919T PL2830645T3 PL 2830645 T3 PL2830645 T3 PL 2830645T3 PL 13716919 T PL13716919 T PL 13716919T PL 13716919 T PL13716919 T PL 13716919T PL 2830645 T3 PL2830645 T3 PL 2830645T3
Authority
PL
Poland
Prior art keywords
neuregulin
peripheral nerve
nerve injury
treating peripheral
treating
Prior art date
Application number
PL13716919T
Other languages
English (en)
Inventor
Anthony O Caggiano
Anthony J Bella
Anindita Ganguly
Jennifer Iaci
Thomas Parry
Raymond Warren Colburn
Original Assignee
Acorda Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics Inc filed Critical Acorda Therapeutics Inc
Publication of PL2830645T3 publication Critical patent/PL2830645T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1883—Neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL13716919T 2012-03-30 2013-03-29 Neuregulina do zastosowania w leczeniu uszkodzenia nerwu obwodowego PL2830645T3 (pl)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261618381P 2012-03-30 2012-03-30
US201261674060P 2012-07-20 2012-07-20
US201261693585P 2012-08-27 2012-08-27
US201261693589P 2012-08-27 2012-08-27
US201361785419P 2013-03-14 2013-03-14
PCT/US2013/034634 WO2013149163A1 (en) 2012-03-30 2013-03-29 Use of neuregulin to treat peripheral nerve injury
EP13716919.9A EP2830645B1 (en) 2012-03-30 2013-03-29 Neuregulin for use in treating peripheral nerve injury

Publications (1)

Publication Number Publication Date
PL2830645T3 true PL2830645T3 (pl) 2018-01-31

Family

ID=48128617

Family Applications (2)

Application Number Title Priority Date Filing Date
PL13716919T PL2830645T3 (pl) 2012-03-30 2013-03-29 Neuregulina do zastosowania w leczeniu uszkodzenia nerwu obwodowego
PL17187879T PL3278811T3 (pl) 2012-03-30 2013-03-29 Zastosowanie ggf2 do leczenia bólu neuropatycznego po urazie nerwów obwodowych

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL17187879T PL3278811T3 (pl) 2012-03-30 2013-03-29 Zastosowanie ggf2 do leczenia bólu neuropatycznego po urazie nerwów obwodowych

Country Status (16)

Country Link
US (3) US20150094263A1 (pl)
EP (3) EP3842059A1 (pl)
JP (4) JP6420233B2 (pl)
CN (2) CN104321072A (pl)
AU (4) AU2013237896B2 (pl)
BR (1) BR112014024308B1 (pl)
CA (1) CA2869070A1 (pl)
DK (2) DK3278811T3 (pl)
ES (2) ES2857810T3 (pl)
HK (2) HK1206632A1 (pl)
IL (3) IL288785B2 (pl)
MX (1) MX354598B (pl)
NZ (1) NZ700546A (pl)
PL (2) PL2830645T3 (pl)
PT (2) PT2830645T (pl)
WO (1) WO2013149163A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011000696A (es) 2008-07-17 2011-07-29 Acorda Therapeutics Inc Dosificacion terapeutica de una neurregulina o una subsecuencia de la misma para el tratamiento o la profilaxis de insuficiencia cardiaca.
KR102379876B1 (ko) 2009-10-14 2022-03-30 아코르다 쎄라퓨틱스 인코포레이티드 말초 신경 손상을 치료하기 위한 뉴레귤린의 용도
ITUB20155471A1 (it) * 2015-11-11 2017-05-11 Univ Degli Studi Di Torino Coniugato della neuregulina 1 per il trattamento delle lesioni dei nervi periferici
EP4338672A3 (en) * 2015-12-04 2024-07-17 University Of Iowa Research Foundation System for screening delirium patients for the presence of encephalopathy
US11511136B2 (en) 2017-11-17 2022-11-29 The Research Foundation For The State University Of New York Method for treating damaged peripheral nerves using x-ray microbeam irradiation
CN110946991A (zh) * 2018-09-27 2020-04-03 广州中医药大学(广州中医药研究院) 神经调节蛋白1的应用
CA3149371A1 (en) * 2019-08-01 2021-02-04 Mark Evans Methods and apparatus for reducing the risk, and identifying the existence, of neurological injury to a human fetus during and before labor
CN116116737B (zh) * 2023-04-14 2023-06-30 新华手术器械有限公司 止血钳毛坯自动上料装置及使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US888A (en) 1838-08-20 perkins
US7037A (en) 1850-01-22 Grid-ikon slide-valve
US5716930A (en) 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US5530109A (en) 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US7037888B1 (en) 1992-04-03 2006-05-02 Acorda Therapeutics, Inc. Methods for treating muscle diseases and disorders
US6087323A (en) * 1992-04-03 2000-07-11 Cambridge Neuroscience, Inc. Use of neuregulins as modulators of cellular communication
CA2306228A1 (en) * 1997-10-14 1999-04-22 Cambridge Neuroscience, Inc. Therapeutic methods comprising use of a neuregulin
CA2409996C (en) * 2000-05-23 2016-03-01 Cenes Pharmaceuticals, Inc. Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
US20100286043A1 (en) * 2007-10-05 2010-11-11 Tufts Medical Center, Inc. Use of neuregulin-1 in reducing brain damage
WO2009108390A2 (en) * 2008-02-29 2009-09-03 Acorda Therapeutics, Inc. Method for achieving desired glial growth factor 2 plasma levels
MX2011000696A (es) * 2008-07-17 2011-07-29 Acorda Therapeutics Inc Dosificacion terapeutica de una neurregulina o una subsecuencia de la misma para el tratamiento o la profilaxis de insuficiencia cardiaca.
JP5826742B2 (ja) * 2009-05-07 2015-12-02 ドンコック ファーマシューティカル カンパニー リミテッド 神経損傷及び神経疾患の予防または治療用薬学組成物
KR102379876B1 (ko) * 2009-10-14 2022-03-30 아코르다 쎄라퓨틱스 인코포레이티드 말초 신경 손상을 치료하기 위한 뉴레귤린의 용도
US20130143805A1 (en) * 2010-08-13 2013-06-06 Georgetown University Ggf2 and methods of use

Also Published As

Publication number Publication date
JP2017149746A (ja) 2017-08-31
CA2869070A1 (en) 2013-10-03
US20230117985A1 (en) 2023-04-20
PL3278811T3 (pl) 2021-08-02
BR112014024308A8 (pt) 2018-01-23
MX2014011838A (es) 2015-03-09
HK1249038A1 (zh) 2018-10-26
WO2013149163A1 (en) 2013-10-03
DK2830645T3 (da) 2017-11-20
EP3842059A1 (en) 2021-06-30
JP7108724B2 (ja) 2022-07-28
IL288785B (en) 2022-11-01
DK3278811T3 (da) 2021-03-01
NZ700546A (en) 2017-05-26
EP3278811B1 (en) 2020-12-02
IL273186B (en) 2022-01-01
JP2015514096A (ja) 2015-05-18
AU2019202401B2 (en) 2020-10-15
CN106511971A (zh) 2017-03-22
PT2830645T (pt) 2017-11-28
HK1206632A1 (en) 2016-01-15
AU2013237896B2 (en) 2017-11-02
PT3278811T (pt) 2021-03-03
IL273186A (en) 2020-04-30
IL234882B (en) 2020-03-31
IL234882A0 (en) 2014-12-31
AU2018200592A1 (en) 2018-02-15
EP3278811A1 (en) 2018-02-07
US20150094263A1 (en) 2015-04-02
IL288785B2 (en) 2023-03-01
EP2830645B1 (en) 2017-08-30
AU2020260539A1 (en) 2020-11-26
IL288785A (en) 2022-02-01
EP2830645A1 (en) 2015-02-04
JP2021059605A (ja) 2021-04-15
BR112014024308B1 (pt) 2021-11-30
AU2019202401A1 (en) 2019-05-02
US20160346353A1 (en) 2016-12-01
CN104321072A (zh) 2015-01-28
MX354598B (es) 2018-03-12
JP6420233B2 (ja) 2018-11-07
ES2647917T3 (es) 2017-12-27
JP2019131582A (ja) 2019-08-08
ES2857810T3 (es) 2021-09-29
BR112014024308A2 (pt) 2017-08-08
AU2013237896A1 (en) 2014-10-16

Similar Documents

Publication Publication Date Title
HK1207076A1 (en) Compounds and methods for antiviral treatment
EP3698782C0 (en) CARBAMATE COMPOUNDS FOR USE IN THERAPY
HRP20180659T1 (hr) Disperzija amorfne krutine, namijenjena upotrebi u liječenju raka na mozgu
PL2911548T3 (pl) Urządzenie do wykonywania zabiegów na włosach
EP2856962A4 (en) ENERGY-RELATED TREATMENT TOOL
EP2819703A4 (en) TREATMENT OF PAIN
SG11201500685PA (en) Warm-cool beauty treatment device
IL288785A (en) Preparations containing neuragiolin and their uses for the treatment of peripheral nerve damage
EP2906208A4 (en) THERAPEUTIC TREATMENT
HK1209424A1 (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of reperfusion injury
EP2922511A4 (en) TREATMENT DEVICE FOR EYELID
EP2903605A4 (en) ANGIOTENSIN FOR THE TREATMENT OF BRAIN STATES
HK1210585A1 (en) Alpha-1-microglobulin for use in the treatment of mitochondria- related diseases -1
EP2932922A4 (en) TREATMENT TOOL
GB201221123D0 (en) Device for photodynamic treatment
HK1208598A1 (en) Methods and compositions for treating pain
GB2497886B (en) Hair treatment methods
SI2872176T1 (sl) Karboranilporfirin za uporabo pri zdravljenju raka
EP2856963A4 (en) ENERGY-RELATED TREATMENT TOOL
GB201213782D0 (en) Process and dressing
EP2904981A4 (en) TREATMENT TOOL
GB2500999B (en) Hair treatment methods
ZA201407164B (en) Device for use in the treatment hyperbilirubinemia
IL236505B (en) Enoxacin for use in the treatment of motor neuron diseases
GB201223371D0 (en) Novel mucinase for use in therapy or prophylaxis